✦ LIBER ✦

Preparation of new 9-alkylthio-1,2,3,4-tetrahydroacridine monomers and dimers

✍ Scribed by Giovannangeli, Genevieve; Soyfer, Jean Claude; Galy, Jean Pierre; Barbe, Jacques

Book ID: 120834593
Publisher: American Chemical Society
Year: 1986
Tongue: English
Weight: 320 KB
Volume: 31
Category: Article
ISSN: 0021-9568
DOI: 10.1021/je00043a038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New Derivatives of 9-Amino-1,2,3,4-tetra

New Derivatives of 9-Amino-1,2,3,4-tetrahydroacridine

✍ Brian, W. P.; Souther, B. L. 📂 Article 📅 1965 🏛 American Chemical Society 🌐 English ⚖ 250 KB

ChemInform Abstract: Synthesis of Acetyl

ChemInform Abstract: Synthesis of Acetylcholinesterase Inhibitors on the Basis of 9-Isothiocyanato-1,2,3,4-tetrahydroacridine: 2-[(1,2,3,4-Tetrahydroacridin-9-yl)imino] -3-substituted-1,3-thiazolidin-4-ones (VI).

✍ Pavol Kristian; Slavka Hamulakova; Juraj Bernat; Jan Imrich; Gundula Voss; Tatia 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 1 views

1,2,4,5-Tetraaza-3,6-diborinane monomers

1,2,4,5-Tetraaza-3,6-diborinane monomers and dimers

✍ Miller, John Joseph; Johnson, Frederic Allan 📂 Article 📅 1970 🏛 American Chemical Society 🌐 English ⚖ 698 KB

Synthesis of halogen derivatives of 9-ar

Synthesis of halogen derivatives of 9-arylamino-1,2,3,4-tetrahydroacridines

✍ M. E. Konshin 📂 Article 📅 1970 🏛 Springer US 🌐 English ⚖ 174 KB

Bioactivation of 2-(Alkylthio)-1,3,4-Thi

Bioactivation of 2-(Alkylthio)-1,3,4-Thiadiazoles and 2-(Alkylthio)-1,3-Benzothiazoles

✍ Yang, Yanou; Qiu, Feng; Josephs, Jonathan L.; Humphreys, W. Griffith; Shu, Yue-Z 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 569 KB

Clinical pharmacokinetics of intravenous

Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine

✍ P. Hartvig; H. Askmark; S. M. Aquilonius; L. Wiklund; B. Lindström 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 428 KB

The pharmacokinetics of 9-amino-1,2,3,4-tetrahydroacridine; tacrine, THA, was studied after intravenous administration and following the first and last oral doses of a seven week clinical trial involving 8 patients with amyotrophic lateral sclerosis, ALS. Two surgical patients given intravenous THA